Viewing Study NCT00451295


Ignite Creation Date: 2025-12-24 @ 1:53 PM
Ignite Modification Date: 2025-12-27 @ 9:13 PM
Study NCT ID: NCT00451295
Status: TERMINATED
Last Update Posted: 2011-11-15
First Post: 2007-03-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia
Sponsor: Tanabe Pharma Corporation
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: MCI-196-E09
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators